- Grand opening of Interwood’s 16th Exclusive Brand outlet at Hyderabad
- Rakesh Sharma Director of ITV Group elected as new president of INS
- Asian Games: India stun Korea for historic maiden entry in men's team badminton final
- Asian Games: India thrash Pakistan 10-2, hand archrivals biggest defeat ever
- Hockey Association of Odisha beat Hockey Jharkhand in Sub-Junior men, women finals
- Day after alleged manhandling, model turned actress Archana Gautam suspended from Congress
- Asian Games: Indian Men's Hockey Team stuns Pakistan, picks dominant 10-2 win
- Foreign intelligence agency involved in terror incidents in Pak, claims Minister
- Tribal party sponsored 12-hour bandh hits normal life in Tripura’s tribal areas
- US misses the 'bigger picture' on row with Canada, says Jaishankar
New treatment shows promise for some women with cervical cancer
A simple hysterectomy, a surgical procedure where the uterus and cervix is removed, is a safe treatment option that can improve quality of life for...
A simple hysterectomy, a surgical procedure where the uterus and cervix is removed, is a safe treatment option that can improve quality of life for women with early-stage, low-risk cervical cancer, according to results from the phase III clinical trial.
The study states that a simple hysterectomy resulted in similar outcomes in terms of keeping them cancer-free, compared to the standard radical hysterectomy, which removes the uterus, cervix, upper parts of the vagina and other nearby tissues.
Because radical hysterectomy is a more complex surgery, it is associated with more acute and long-term side effects, as well as potential impacts on quality of life and sexual health for patients. “Sexual health and quality of life are very important considerations for patients undergoing cancer treatment,” said Dr. Lori Brotto, a professor of obstetrics and gynaecology at University of British Columbia.
“The findings from this study indicate that patients can expect fewer negative effects on sexual health and many other facets of quality of life with simple hysterectomy while not compromising effects on recurrence and survival rates,” Brotto added.
The study looked at the three-year pelvic recurrence rate and other health outcomes in 700 patients from 12 countries receiving both simple and radical hysterectomies.
The findings, presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, showed that the extra-pelvic recurrence-free survival, the relapse-free survival, and the overall survival were comparable between the two groups.